» Articles » PMID: 31196143

The Clinical and Mutational Spectrum of B3GAT3 Linkeropathy: Two Case Reports and Literature Review

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2019 Jun 15
PMID 31196143
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Proteoglycans are large and structurally complex macromolecules which can be found in abundancy in the extracellular matrix and on the surface of all animal cells. Mutations in the genes encoding the enzymes responsible for the formation of the tetrasaccharide linker region between the proteoglycan core protein and the glycosaminoglycan side chains lead to a spectrum of severe and overlapping autosomal recessive connective tissue disorders, collectively coined the 'glycosaminoglycan linkeropathies'.

Results: We report the clinical findings of two novel patients with a complex linkeropathy due to biallelic mutations in B3GAT3, the gene that encodes glucuronosyltransferase I, which catalyzes the addition of the ultimate saccharide to the linker region. We identified a previously reported c.667G > A missense mutation and an unreported homozygous c.416C > T missense mutation. We also performed a genotype and phenotype-oriented literature overview of all hitherto reported patients harbouring B3GAT3 mutations. A total of 23 patients from 10 families harbouring bi-allelic mutations and one patient with a heterozygeous splice-site mutation in B3GAT3 have been reported. They all display a complex phenotype characterized by consistent presence of skeletal dysplasia (including short stature, kyphosis, scoliosis and deformity of the long bones), facial dysmorphology, and spatulate distal phalanges. More variably present are cardiac defects, joint hypermobility, joint dislocations/contractures and fractures. Seven different B3GAT3 mutations have been reported, and although the number of patients is still limited, some phenotype-genotype correlations start to emerge. The more severe phenotypes seem to have mutations located in the substrate acceptor subdomain of the catalytic domain of the glucuronosyltransferase I protein while more mildly affected phenotypes seem to have mutations in the NTP-sugar donor substrate binding subdomain.

Conclusions: Loss-of-function mutations in B3GAT3 are associated with a complex connective tissue phenotype characterized by disproportionate short stature, skeletal dysplasia, facial dysmorphism, spatulate distal phalanges and -to a lesser extent- joint contractures, joint hypermobility with dislocations, cardiac defects and bone fragility. Based on the limited number of reported patients, some genotype-phenotype correlations start to emerge.

Citing Articles

The toxin mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane to drive skin necrosis.

Hsieh L, Hall B, Newcombe J, Mendum T, Varela S, Umrania Y Elife. 2025; 12.

PMID: 39913180 PMC: 11801798. DOI: 10.7554/eLife.86931.


A Recurrent c.416C>T Variant in the B3GAT3 Gene in the Turkish Population: Report of Two Siblings and Expanding the Clinical Spectrum.

Dasar T, Kolkiran A, Sezer A, Bal E, Kilic E Mol Syndromol. 2024; 15(5):409-420.

PMID: 39359951 PMC: 11444697. DOI: 10.1159/000537869.


Mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane: a new indirect mechanism driving tissue necrosis in infection.

Hsieh L, Hall B, Newcombe J, Mendum T, Santana-Varela S, Umrania Y bioRxiv. 2023; .

PMID: 36865118 PMC: 9980099. DOI: 10.1101/2023.02.21.529382.


Mutant in a Multiplex Family: A Dominant Variant Co-Segregated With Moderate Malformations.

Shen F, Yang Y, Zheng Y, Tu M, Zhao L, Luo Z Front Genet. 2022; 13:824445.

PMID: 35734427 PMC: 9207203. DOI: 10.3389/fgene.2022.824445.


Severe phenotypes of B3GAT3-related disorder caused by two heterozygous variants: a case report and literature review.

Li Y, Zhang C, Zhang H, Feng W, Wang Q, Fan R BMC Med Genomics. 2022; 15(1):27.

PMID: 35151321 PMC: 8841085. DOI: 10.1186/s12920-022-01160-9.


References
1.
Taylan F, Yavas Abali Z, Jantti N, Gunes N, Darendeliler F, Bas F . Two novel mutations in XYLT2 cause spondyloocular syndrome. Am J Med Genet A. 2017; 173(12):3195-3200. DOI: 10.1002/ajmg.a.38470. View

2.
Job F, Mizumoto S, Smith L, Couser N, Brazil A, Saal H . Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype. BMC Med Genet. 2016; 17(1):86. PMC: 5117547. DOI: 10.1186/s12881-016-0344-9. View

3.
LaCroix A, Stabley D, Sahraoui R, Adam M, Mehaffey M, Kernan K . GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome. Am J Hum Genet. 2018; 104(1):35-44. PMC: 6323552. DOI: 10.1016/j.ajhg.2018.11.005. View

4.
Kitagawa H, Tone Y, Tamura J, Neumann K, Ogawa T, Oka S . Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem. 1998; 273(12):6615-8. DOI: 10.1074/jbc.273.12.6615. View

5.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View